Title : DLBCL 1L-What to Expect beyond R-CHOP?

Pub. Date : 2022 Mar 11

PMID : 35326604






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Moreover, a number of targeted agents, especially the Bruton"s tyrosine kinase (BTK) inhibitor Ibrutinib, seem to have activity in certain patient subsets in 1L and are currently being tested in front-line regimens. ibrutinib Bruton tyrosine kinase Homo sapiens
2 Moreover, a number of targeted agents, especially the Bruton"s tyrosine kinase (BTK) inhibitor Ibrutinib, seem to have activity in certain patient subsets in 1L and are currently being tested in front-line regimens. ibrutinib Bruton tyrosine kinase Homo sapiens